# Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver

> **NCT00301106** · PHASE1 · TERMINATED · sponsor: **Max Sung** · enrollment: 2 (actual)

## Conditions studied

- Breast Cancer
- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** adenovirus-mediated human interleukin-12

## Key facts

- **NCT ID:** NCT00301106
- **Lead sponsor:** Max Sung
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** protocol underwent significant revisions, decision made to terminate study and open as new study listed NCT00849459
- **Last updated:** 2017-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301106, "Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00301106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*